As Peptie 19-2.5 is a mimic of LL-37, its potential mechanism of action in models of diet-induced obesity, NASH and insulin resistance may be secondary to reduction of the expression of CD36. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatohepatitis.